Statistics for Low-cost SARS-CoV-2 vaccine homogenization system for Pfizer-BioNTech covid-19 vials
Total visits
| views | |
|---|---|
| Low-cost SARS-CoV-2 vaccine homogenization system for Pfizer-BioNTech covid-19 vials | 62 |
Total visits per month
| views | |
|---|---|
| November 2024 | 2 |
| December 2024 | 2 |
| January 2025 | 4 |
| February 2025 | 8 |
| March 2025 | 0 |
| April 2025 | 0 |
| May 2025 | 0 |
File Visits
| views | |
|---|---|
| Low_cost_SARS_CoV_2_vaccine_homogenizati.pdf(legacy) | 46 |
| Low_cost_SARS_CoV_2_vaccine_homogenizati.pdf | 8 |
Top country views
| views | |
|---|---|
| United States | 11 |
| China | 10 |
| Ireland | 7 |
| Singapore | 4 |
| Colombia | 3 |
| Greece | 3 |
| Portugal | 3 |
| Australia | 2 |
| India | 2 |
| Pakistan | 2 |
| Romania | 2 |
| Belgium | 1 |
| Germany | 1 |
| Spain | 1 |
| Hong Kong SAR China | 1 |
| Indonesia | 1 |
| Kenya | 1 |
| Norway | 1 |
| Philippines | 1 |
| Puerto Rico | 1 |
| Saudi Arabia | 1 |
| South Africa | 1 |